inb-200
spdr s&p biotech,ishares biotechnology,in8bio
['inb-200 ', '$ibb', 'in8bio', '$xbi', '$inab']
$inab in8bio reveals encouraging phase 1 results of inb-200 in glioblastoma at the 2023 asco annual meeting. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt